Fresenius Kabi
Michael Luckau is an accomplished professional in digital product management and innovation within the healthcare sector. Currently serving as the Director of Digital Products & Service Innovations at Fresenius Kabi since June 2024, Michael brings extensive experience from previous roles at Fresenius Medical Care, where responsibilities included driving global digital strategies and overseeing significant medical software and business development initiatives. Michael's career also encompasses leadership positions focused on service portfolio management and product development across various healthcare technologies. Educational qualifications include a Diploma of Advanced Studies in General Management from Rochester-Bern Executive Programs and a Diplom Ingenieur in Biomedical Engineering from the University of Applied Sciences Koblenz.
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.